Chronological Review and Rational and Future Prospects of Cannabis-Based Drug Development
Despite the surge in cannabis chemistry research and its biological and medical activity, only a few cannabis-based pharmaceutical-grade drugs have been developed and marketed to date. Not many of these drugs are Food and Drug Administration (FDA)-approved, and some are still going through regulatio...
Main Authors: | Dvora Namdar, Omer Anis, Patrick Poulin, Hinanit Koltai |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/20/4821 |
Similar Items
-
Structure-Activity Relationship of Cannabis Derived Compounds for the Treatment of Neuronal Activity-Related Diseases
by: Cristina Prandi, et al.
Published: (2018-06-01) -
Currently Available Non-Balloon Devices
by: Hang Lak Lee
Published: (2018-09-01) -
FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022
by: Carla Rizzo, et al.
Published: (2023-04-01) -
Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Look at the Approved and Emerging Therapies
by: Yazeed Sawalha
Published: (2021-12-01) -
Comparison of approval procedures for medical devices in Europe and the USA
by: Vila Wagner Marcel, et al.
Published: (2019-09-01)